The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2019 May 29

PMID 31134067

Citations 32

Authors

Aifen Lin

Wei-Hua Yan

Affiliations

Soon will be listed here.

Abstract

Human leukocyte antigens (HLAs) play various critical roles in both innate and adaptive immunity through processes such as presenting antigens to T cells and serving as ligands for receptors expressed on natural killer (NK) cells. Among the HLA class I family, the clinical significance and biological function of HLA-F have been the least investigated and have remained elusive for a long period of time. Previous studies have revealed that HLA-F expression might be involved in various physiological and pathological processes, such as pregnancy, viral infection, cancer, transplantation, and autoimmune diseases. However, recent data have shown that, akin to other HLA family members, HLA-F molecules can interact with both activating and inhibitory receptors on immune cells, such as NK cells, and can present a diverse panel of peptides. These important findings pave new avenues for investigations regarding the functions of HLA-F as an important immune regulatory molecule. In the present review, we summarize the studies on the role of HLA-F in immune modulation, with a special emphasis placed on the roles of HLA-F and KIR3DS1 interactions in viral infection.

Citing Articles

Prognosis and immune infiltration prediction in neuroblastoma based on neutrophil extracellular traps-related gene signature.

Aierken Y, Tan K, Liu T, Lv Z Sci Rep. 2025; 15(1):5343.

PMID: 39948114 PMC: 11825912. DOI: 10.1038/s41598-025-88608-x.

Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer.

Benitez Fuentes J, Bartolome Arcilla J, Mohamed Mohamed K, Lopez de Sa A, de Luna Aguilar A, Guevara-Hoyer K Cancers (Basel). 2025; 16(24.

PMID: 39766165 PMC: 11675049. DOI: 10.3390/cancers16244266.

Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity.

Spartano S, Faggiano M, Guidi G, DAmbrosio P, Vaisfeld A, Novelli A Int J Mol Sci. 2024; 25(23).

PMID: 39684907 PMC: 11642212. DOI: 10.3390/ijms252313198.

Multi-Omics Characterization of Colon Mucosa and Submucosa/Wall from Crohn's Disease Patients.

Jin L, Macoritto M, Wang J, Bi Y, Wang F, Suarez-Fueyo A Int J Mol Sci. 2024; 25(10).

PMID: 38791146 PMC: 11121447. DOI: 10.3390/ijms25105108.

Inclusion body myositis, viral infections, and TDP-43: a narrative review.

Vacaras V, Vulturar R, Chis A, Damian L Clin Exp Med. 2024; 24(1):91.

PMID: 38693436 PMC: 11062973. DOI: 10.1007/s10238-024-01353-9.

References

WAINWRIGHT S, Biro P, Holmes C . HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern. J Immunol. 1999; 164(1):319-28. DOI: 10.4049/jimmunol.164.1.319. View

Borges L, Cosman D . LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 2000; 11(3):209-17. DOI: 10.1016/s1359-6101(00)00007-1. View

Lepin E, Bastin J, Allan D, Roncador G, Braud V, Mason D . Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol. 2001; 30(12):3552-61. DOI: 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L. View

Lee N, Geraghty D . HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol. 2003; 171(10):5264-71. DOI: 10.4049/jimmunol.171.10.5264. View

Parham P . Influence of KIR diversity on human immunity. Adv Exp Med Biol. 2005; 560:47-50. DOI: 10.1007/0-387-24180-9_6. View

Boyle L, Gillingham A, Munro S, Trowsdale J . Selective export of HLA-F by its cytoplasmic tail. J Immunol. 2006; 176(11):6464-72. DOI: 10.4049/jimmunol.176.11.6464. View

Shobu T, Sageshima N, Tokui H, Omura M, Saito K, Nagatsuka Y . The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation. J Reprod Immunol. 2006; 72(1-2):18-32. DOI: 10.1016/j.jri.2006.02.001. View

Geraghty D, Wei X, Orr H, Koller B . Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med. 1990; 171(1):1-18. PMC: 2187653. DOI: 10.1084/jem.171.1.1. View

Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E . Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A. 2006; 103(44):16412-7. PMC: 1637596. DOI: 10.1073/pnas.0605228103. View

10.

Carr W, Rosen D, Arase H, Nixon D, Michaelsson J, Lanier L . Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol. 2007; 178(2):647-51. PMC: 2561215. DOI: 10.4049/jimmunol.178.2.647. View

11.

Arosa F, Santos S, Powis S . Open conformers: the hidden face of MHC-I molecules. Trends Immunol. 2007; 28(3):115-23. DOI: 10.1016/j.it.2007.01.002. View

12.

Gillespie G, Bashirova A, Dong T, McVicar D, Rowland-Jones S, Carrington M . Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res Hum Retroviruses. 2007; 23(3):451-5. DOI: 10.1089/aid.2006.0165. View

13.

Barbour J, Sriram U, Caillier S, Levy J, Hecht F, Oksenberg J . Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 2007; 3(4):e43. PMC: 1853116. DOI: 10.1371/journal.ppat.0030043. View

14.

Lin A, Xu H, Yan W . Modulation of HLA expression in human cytomegalovirus immune evasion. Cell Mol Immunol. 2007; 4(2):91-8. View

15.

Liang S, Ristich V, Arase H, Dausset J, Carosella E, Horuzsko A . Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway. Proc Natl Acad Sci U S A. 2008; 105(24):8357-62. PMC: 2448841. DOI: 10.1073/pnas.0803341105. View

16.

Li H, Peng S, Cui Y, Fu Q, Zhou Y, Wang Q . Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1. Protein Pept Lett. 2009; 17(5):547-54. DOI: 10.2174/092986610791112657. View

17.

Goodridge J, Burian A, Lee N, Geraghty D . HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J Immunol. 2010; 184(11):6199-208. PMC: 3777411. DOI: 10.4049/jimmunol.1000078. View

18.

Lee N, Ishitani A, Geraghty D . HLA-F is a surface marker on activated lymphocytes. Eur J Immunol. 2010; 40(8):2308-18. PMC: 3867582. DOI: 10.1002/eji.201040348. View

19.

Heinrichs H, Orr H . HLA non-A,B,C class I genes: their structure and expression. Immunol Res. 1990; 9(4):265-74. DOI: 10.1007/BF02935526. View

20.

Yoder J, Litman G . The phylogenetic origins of natural killer receptors and recognition: relationships, possibilities, and realities. Immunogenetics. 2010; 63(3):123-41. PMC: 3691731. DOI: 10.1007/s00251-010-0506-4. View